Healthcare
Qrons Inc.(QRON)
Live Price
Offline$0.0111
+0.00% today
1Y Change
-83.72%
Window
Jun 23, 2025 โ May 27, 2026
- Market Cap
- $199.80K
- Revenue Growth
- 0.0%
- EPS Growth
- +93.1%
- Dividend Yield
- 0.0%
Coverage: 197 bars ยท Jun 23, 2025 โ May 27, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Qrons Inc. (QRON) is a Healthcare stock with a market cap of $199.80K and listed on OTC. The stock last traded around $0.01 and down 83.7% across the available one-year price window (Jun 23, 2025 โ May 27, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +93.1%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +93.1%, free cash flow +10.0% with operating margin 0.0% and ROIC 236.1%. Stock Foundry combines QRON price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
0.0% vs +7.6% peer median
Operating Margin
Below sector median
0.0% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2023 was reported on Sep 30, 2023, but the surprise data is still limited.
The setup is mixed rather than one-directional
Revenue is 0.0% and EPS is +93.1%, while operating margin sits near 0.0%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -26.7% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2023 Sep 30, 2023 | โ | +0.0% | -26.7% | -1.8% |
2023 Jun 30, 2023 | โ | +0.0% | -26.7% | -1.8% |
2023 Mar 31, 2023 | โ | +0.0% | -26.7% | -1.8% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
QRON
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
QRON Max Drawdown
-84.14%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for QRON and SPY.
Company Overview
Qrons Inc.
Other OTC
Qrons Inc., a biotechnology company, engages in development of biotech products, treatments, and technologies to combat neuronal diseases. Its product candidates include QS100, an injury specific, 3D printable, implantable mesenchymal stem cells (MSCs)-synthetic hydrogel to treat penetrating brain injuries; and QS200, an injectable MSCs-synthetic hydrogel for the treatment of concussions and other diffused axonal injuries. The company was formerly known as BioLabMart Inc. and changed its name to Qrons Inc. in August 2017. Qrons Inc. was incorporated in 2016 and is based in Long Island City, New York.
- Leadership
- Cory J. Rosenberg
- IPO Date
- Sep 12, 2017
- Employees
- 10
- Street Address
- 28-10 Jackson Avenue
- Mailing
- Long Island City, NY, 11101
- Region
- Long Island City, NY, US
- Reporting Currency
- USD
- Investor Line
- 212 945 2080
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- โ
- Price/Book
- โ
Growth
- Revenue
- 0.0%
- EPS
- +93.1%
- Free Cash Flow
- +10.0%
Profitability
- Gross Margin
- 0.0%
- Operating Margin
- 0.0%
- Net Margin
- 0.0%
- ROE
- 5.8%
- ROIC
- 236.1%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.00
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.